Cargando…

Notes to applicants for marketing authorizations on the production and quality control of monoclonal antibodies of murine origin intended for use in man

Detalles Bibliográficos
Autor principal: Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 1989
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133254/
https://www.ncbi.nlm.nih.gov/pubmed/2793873
http://dx.doi.org/10.1016/0092-1157(89)90013-9
_version_ 1783517591711514624
author Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy
author_facet Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy
author_sort Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy
collection PubMed
description
format Online
Article
Text
id pubmed-7133254
institution National Center for Biotechnology Information
language English
publishDate 1989
publisher Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71332542020-04-08 Notes to applicants for marketing authorizations on the production and quality control of monoclonal antibodies of murine origin intended for use in man Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy J Biol Stand Article Published by Elsevier Ltd. 1989 2004-04-15 /pmc/articles/PMC7133254/ /pubmed/2793873 http://dx.doi.org/10.1016/0092-1157(89)90013-9 Text en Copyright © 1989 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy
Notes to applicants for marketing authorizations on the production and quality control of monoclonal antibodies of murine origin intended for use in man
title Notes to applicants for marketing authorizations on the production and quality control of monoclonal antibodies of murine origin intended for use in man
title_full Notes to applicants for marketing authorizations on the production and quality control of monoclonal antibodies of murine origin intended for use in man
title_fullStr Notes to applicants for marketing authorizations on the production and quality control of monoclonal antibodies of murine origin intended for use in man
title_full_unstemmed Notes to applicants for marketing authorizations on the production and quality control of monoclonal antibodies of murine origin intended for use in man
title_short Notes to applicants for marketing authorizations on the production and quality control of monoclonal antibodies of murine origin intended for use in man
title_sort notes to applicants for marketing authorizations on the production and quality control of monoclonal antibodies of murine origin intended for use in man
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133254/
https://www.ncbi.nlm.nih.gov/pubmed/2793873
http://dx.doi.org/10.1016/0092-1157(89)90013-9
work_keys_str_mv AT committeeforproprietarymedicinalproductsadhocworkingpartyonbiotechnologypharmacy notestoapplicantsformarketingauthorizationsontheproductionandqualitycontrolofmonoclonalantibodiesofmurineoriginintendedforuseinman